BeOne Medicines (49BA) Q2 2024 Earnings Report
DE:49BA Q2 2024 EPS Results
- Actual EPS
- -EUR 1.03
- Consensus EPS
- -EUR 1.96
- Beat/Miss
- Beat by +EUR 0.93
- One Year Ago EPS
- -EUR 3.26
DE:49BA Q2 2024 Revenue Results
- Actual Revenue
- EUR 831.00M
- Expected Revenue
- EUR 725.57M
- Beat/Miss
- Beat by +EUR 105.43M
- YoY Revenue Growth
- +57.70%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/26/2024
- Time
- After Close
- Conference Call
- Monday, August 26, 2024
DE:49BA Upcoming Earnings
BeOne Medicines's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:49BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 1.70- | 0.98 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 1.491.84 | 0.81 | 125.27% (+1.02) | |
| May 06, 2026 | 2026 (Q1) | 0.871.75 | 0 | ― | |
| Feb 26, 2026 | 2025 (Q4) | 1.110.54 | -1.28 | 141.96% (+1.82) | |
| Nov 06, 2025 | 2025 (Q3) | 0.760.98 | -1.03 | 194.78% (+2.01) | |
| Aug 06, 2025 | 2025 (Q2) | 0.350.81 | -1.03 | 179.13% (+1.84) | |
| May 07, 2025 | 2025 (Q1) | -0.510.00 | -2.16 | 100.00% (+2.16) | |
| Feb 27, 2025 | 2024 (Q4) | -0.91-1.28 | -3.16 | 59.49% (+1.88) | |
| Nov 12, 2024 | 2024 (Q3) | -1.00-1.03 | 1.8 | -157.21% (-2.83) | |
| Aug 26, 2024 | 2024 (Q2) | -1.96-1.03 | -3.26 | 68.41% (+2.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
